Furthermore, estrogen could inhibit etoposide-induced apoptosis of human osteosarcoma cells via mediating estrogen-β receptor (Kallio et al., 2008) therefore targeting estrogen receptor positive cells is clinically important. This evidence concerns the gene ESR1 and osteosarcoma.